The association of depression and anxiety with cardiac autonomic activity: The role of confounding effects of antidepressants

Depress Anxiety. 2019 Dec;36(12):1163-1172. doi: 10.1002/da.22966. Epub 2019 Oct 17.

Abstract

Background: Depression and anxiety may unfavorably impact on cardiac autonomic dysregulation. However, it is unclear whether this relationship results from a causal effect or may be attributable to confounding factors. We tested the relationship between depression and anxiety with heart rate (HR) and heart rate variability (HRV) across a 9-year follow-up (FU) period and investigated possible confounding by antidepressant use and genetic pleiotropy.

Methods: Data (no. of observations = 6,994, 65% female) were obtained from the longitudinal Netherlands Study of Depression and Anxiety, with repeated waves of data collection of HR, HRV, depression, anxiety, and antidepressant use. Summary statistics from meta-analyses of genome-wide association studies were used to derive polygenic risk scores of depression, HR, and HRV.

Results: Across the 9-year FU, generalized estimating equations analyses showed that the relationship between cardiac autonomic dysregulation and depression/anxiety rendered nonsignificant after adjusting for antidepressant use. A robust association was found between antidepressant use (especially tricyclic antidepressants, selective serotonin, and noradrenalin reuptake inhibitors) and unfavorable cardiac autonomic activity across all waves. However, no evidence was found for a genetic correlation of depression with HR and HRV, indicating that confounding by genetic pleiotropy is minimal.

Conclusions: Our results indicate that the association between depression/anxiety and cardiac autonomic dysregulation does not result from a causal pathway or genetic pleiotropy, and these traits might therefore not be inevitably linked. Previously reported associations were likely confounded by the use of certain classes of antidepressants.

Keywords: antidepressants; anxiety/anxiety disorders; depression; electrophysiology; gene-environment; genetics; stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use*
  • Antidepressive Agents, Tricyclic / pharmacology
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Anxiety / drug therapy*
  • Anxiety / genetics
  • Anxiety / physiopathology
  • Anxiety Disorders / drug therapy
  • Anxiety Disorders / genetics
  • Anxiety Disorders / physiopathology
  • Autonomic Nervous System / drug effects*
  • Autonomic Nervous System / physiopathology*
  • Confounding Factors, Epidemiologic*
  • Depression / drug therapy*
  • Depression / genetics
  • Depression / physiopathology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / genetics
  • Depressive Disorder / physiopathology
  • Female
  • Genome-Wide Association Study
  • Heart / innervation*
  • Heart Rate / drug effects
  • Heart Rate / genetics
  • Heart Rate / physiology
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Multifactorial Inheritance
  • Netherlands
  • Young Adult

Substances

  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic